Cosmo Bio Co (TSE:3386) Other Stockholders Equity: 円1,687 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3386 Cosmo Bio Co Ltd TSE:3386
72 GF Score
Price 円1,234.00
GF Value 円1,248.34
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cosmo Bio Co Other Stockholders Equity?

Cosmo Bio Co TSE:3386 72 Other Stockholders Equity is 円1,687 Mil as of Dec. 2025. GuruFocus rates TSE:3386 with a GF Score™ of 72/100 and a GF Value™ of 円1,248.34 (Fairly Valued). The stock has 4 warning signs investors should review.

Cosmo Bio Co's Other Stockholders Equity for the quarter that ended in Dec. 2025 was 円1,687 Mil.

Cosmo Bio Co's quarterly Other Stockholders Equity increased from Dec. 2024 (円1,211 Mil) to Jun. 2025 (円1,327 Mil) and increased from Jun. 2025 (円1,327 Mil) to Dec. 2025 (円1,687 Mil).

Cosmo Bio Co's annual Other Stockholders Equity increased from Dec. 2023 (円654 Mil) to Dec. 2024 (円1,211 Mil) and increased from Dec. 2024 (円1,211 Mil) to Dec. 2025 (円1,687 Mil).

Cosmo Bio Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cosmo Bio Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co Other Stockholders Equity Chart

Cosmo Bio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 574.00 530.00 654.00 1,211.00 1,687.00

Cosmo Bio Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 654.00 1,217.00 1,211.00 1,327.00 1,687.00
TSE:3386
72GF Score
Cosmo Bio Co Ltd TSE:3386
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo Bio Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円1,687 Mil mean?
Cosmo Bio Co (TSE:3386) has a Other Stockholders Equity of 円1,687 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cosmo Bio Co and its competitors.
Is Cosmo Bio Co's Other Stockholders Equity too high?
Cosmo Bio Co's current Other Stockholders Equity is 円1,687 Mil. Overall, Cosmo Bio Co has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cosmo Bio Co's Other Stockholders Equity compare to TMO and DHR?
Cosmo Bio Co's Other Stockholders Equity of 円1,687 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cosmo Bio Co and its competitors. Cosmo Bio Co's current Other Stockholders Equity is 円1,687 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo Bio Co stock overvalued right now?
Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,248.34, compared to a current price of 円1,234.00 — trading 1.1% below its estimated fair value. The current Other Stockholders Equity is 円1,687 Mil. Cosmo Bio Co's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current Other Stockholders Equity is 円1,687 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be undervalued. The current stock price of 円1,234.00 is trading 1.1% below its estimated GF Value™ of 円1,248.34. GuruFocus considers Cosmo Bio Co to be Fairly Valued.

Key valuation signals for TSE:3386:

  • Other Stockholders Equity: 円1,687 Mil
  • GF Value™: 円1,248.34 vs. price of 円1,234.00 (1.1% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo Bio Co Business Description

Address 2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.
72GF Score

Get the complete analysis for TSE:3386

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,234.00
Price
円1,248.34
GF Value